The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
For the full year, standalone gross revenue crossed Rs. 1,700 crore
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
The new facility marks Align’s first manufacturing presence in India and its fourth globally
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Subscribe To Our Newsletter & Stay Updated
